Based on recent data, Axsome Therapeutics, Inc. (AXSM) shows an Average True Range (ATR) of 6.18 and an Enterprise Value of 3.17B. Its average trading volume over the past 3 months is 678.03K, indicating liquidity. These fundamental metrics provide insight into AXSM's underlying financial health and market activity.
| ATR | 6.18 |
| Enterprise Value | 3.17B |
| Avg Vol (3 Months) | 678.03K |
| Avg Vol (10 Days) | 1.65M |
Axsome Therapeutics, Inc. (AXSM) technical indicators as of May 5, 2026: the SMA 20 is -9.83%, SMA 50 at -5.89%, and SMA 200 at 22.82%. The RSI 14 value is 31.9, suggesting its current momentum. These technical analysis signals help assess AXSM's price trends and potential future movements.
| SMA 20 | -9.83% |
| SMA 50 | -5.89% |
| SMA 200 | 22.82% |
| RSI 14 | 31.9 |
Axsome Therapeutics, Inc. (AXSM) stock performance overview as of May 5, 2026: The 52-week high is $234.29 (currently -14.78% below), and the 52-week low is $96.09 (currently 87.6% above). Over the past year, AXSM's performance is 96.93%, compared to the S&P 500's 16.14% change.
| 52-Week High | 234.29 |
| 52-Week High Chg | -14.78% |
| 52-Week Low | 96.09 |
| 52-Week Low Chg | +87.60% |
| S&P 500 52-Week Chg | 16.14% |
According to market data, Axsome Therapeutics, Inc. (AXSM) stock's recent performance metrics show that over the last month, AXSM is 24.66%, with a Year-to-Date (YTD) performance of 1.02%. Over the past year, the stock has seen a 96.93% change. These figures summarize AXSM's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 234.29 | 234.29 | 234.29 | 234.29 | 234.29 | 234.29 |
| Low | 180 | 159.92 | 152.28 | 123.5 | 96.09 | 152.28 |
| Performance | +4.34% | +24.66% | +44.21% | +68.22% | +96.93% | +1.02% |
According to current financial data, AXSM stock's P/E (TTM) ratio is -63.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for AXSM, including P/S (18.32), P/B (212.07), and P/FCF (-124.57), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AXSM | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -63.2 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 18.32 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 212.07 | 0.2 | 8293.8 | 4.61 |
| P/FCF (TTM) | -124.57 | -1.48 | -445.49 | 31.99 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep